戻る Agenda
Does the current regulatory framework enable future science and technology along the product lifecycle?
Session Chair(s)
Sabine Atzor, MPHARM, RPH
Head of EU Regulatory Policies
F. Hoffmann-La Roche Ltd, Switzerland
Shayesteh Fürst-Ladani, MBA, MS
CEO
SFL Regulatory Affairs & Scientific Communication, Switzerland
The session will be an interactive panel discussion with representatives from the EMA and various DGs of the European Commission (SANTE, CONNECT, GROW), patient representatives on the fitness of the European regulatory framework for the innovative personalised healthcare solutions to come. It will build on other sessions where such solutions are presented and discussed in details (e.g. Session 0307 Emerging and Transforming Technologies)
Speaker(s)
Panelist
Zaide Frias, PHARMD
European Medicines Agency, Netherlands
Head of Digital Business Transformation Task Force
Panelist
Ceri Thompson
European Commission, Belgium
Panelist
Tapani Piha
FIPRA, Belgium
Special Adviser to the Finnish Ministry of Social Affairs and Health Former Head
David Haerry
EATG, Switzerland
Patient Advocate
Panelist
Aimad Torqui
MEB, Netherlands
Head of Division European cooperation and veterinary affairs